HES7 is involved in the segmentation of the vertebral column during embryonic development. It is essential for the proper formation of somites, which are the precursor tissues of the vertebrae, ribs, and associated tendons and muscles. Disruptions in the function of HES7 can lead to congenital abnormalities such as spondylocostal dysostosis (SCD), a condition characterized by extensive hemivertebrae, truncal shortening, and abnormally aligned ribs .
The Notch signaling pathway is a highly conserved cell signaling system present in most multicellular organisms. It regulates cell fate decisions, proliferation, and apoptosis. HES7 is a direct target of this pathway and is part of a negative feedback mechanism required to attenuate Notch signaling. This regulation is crucial for maintaining the balance between cell differentiation and proliferation .
Mutations in the HES7 gene have been linked to autosomal recessive forms of spondylocostal dysostosis. These mutations can impair the protein’s ability to repress gene expression, leading to abnormal vertebral segmentation. Functional analyses have shown that mutant HES7 proteins are unable to bind DNA or form heterodimers, which are necessary for their repressive function .
Research into HES7 and its role in the Notch signaling pathway has provided valuable insights into the mechanisms of vertebral development and congenital disorders. Understanding these processes can lead to better diagnostic and therapeutic approaches for conditions like spondylocostal dysostosis.